JD Health (6618.HK) Financial Analysis & Valuation | Quarter Chart
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and t... more
JD Health International Inc., an investment holding company, operates an online healthcare platform ... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $14.18B | Exchange | HKSE |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | CN | CEO | Dong Cao |
| IPO Date | 2020-12-08 | CAGR | 38.09% |
| Employees | 6,018 | Website | ir.jdhealth.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
6618.HK chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $7.03B | P/E | 15.19 | Forward P/E | 13.78 | PEG | 0.48 |
| P/S | 0.09 | P/B | 0.12 | P/CF | 0.68 | P/FCF | 0.69 |
| Sales | $21.29B | Sales 1Y | 32.47% | Sales 3Y | 505.72% | Sales 5Y | — |
| EPS | $0.29 | EPS 1Y | 148.96% | EPS 3Y | -220.67% | EPS 5Y | — |
| Sales QoQ | 5.69% | EPS QoQ | 21.84% | Sales QoQ Avg | 9.34% | EPS QoQ Avg | 13.3% |
| Gross Margin | 25.29% | Operating Margin | 6.1% | Profit Margin | 7.86% | ROCE | 7.65% |
| ROA | 7% | ROE | 10% | Altman Z Score | 5.25 | Piotroski Score | 6 |
| Current Ratio | 2.69 | Quick Ratio | 2.34 | Cash Ratio | 0.95 | Op. CF Ratio | 0.19 |
| Debt/Equity | 0.01 | Debt/Assets | 0.01 | Lt Debt/Equity | 0.01 | Lt Debt/Cap. | — |
| Intrst Cov. | 309.93 | Inventory Turnover | 7.94 | Asset Turnover | 0.93 | Receivables Turnover | 143.4 |
| Enterprise Value | $7.03B | P/E Ratio | 15.19 |
| Forward P/E | 13.78 | PEG Ratio | 0.48 |
| P/S Ratio | 0.09 | P/B Ratio | 0.12 |
| P/CF Ratio | 0.68 | P/FCF Ratio | 0.69 |
| EPS | $0.29 | EPS Growth 1Y | 148.96% |
| EPS Growth 3Y | -220.67% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 32.47% | Gross Margin | 25.29% |
| Operating Margin | 6.1% | Profit Margin | 7.86% |
| ROE | 10% | ROA | 7% |
| ROCE | 7.65% | Current Ratio | 2.69 |
| Quick Ratio | 2.34 | Cash Ratio | 0.95 |
| Debt/Equity | 0.01 | Interest Coverage | 309.93 |
| Altman Z Score | 5.25 | Piotroski Score | 6 |
JD Health (6618.HK) valuation & financials
JD Health (6618.HK) has a market capitalization of $14.18B and trades at a price-to-earnings ratio of 15.2. It operates in the Healthcare sector (Medical - Care Facilities).
JD Health's revenue grew +32.5% over the last year.
JD Health's next earnings report is scheduled for March 29, 2027 (provider scheduled date); analysts estimate EPS of $0.17. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)